'Most feared' ac­tivist in­vestor in Amer­i­ca has ze­roed in on Bris­tol-My­ers Squibb. Is he plan­ning to de­rail the $74B Cel­gene buy­out?

The “most feared man in cor­po­rate Amer­i­ca” has just set his sights on Bris­tol-My­ers Squibb. And that may make some of Bris­tol-My­ers more than a lit­tle un­com­fort­able this morn­ing as they con­tin­ue to push their con­tro­ver­sial $74 bil­lion Cel­gene buy­out.

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA